BioNTech 将来の成長
Future 基準チェック /06
BioNTech利益と収益がそれぞれ年間0.3%と5.8%増加すると予測されています。EPS は年間 減少すると予想されています。自己資本利益率は 3 年後に-1.8% 1.4%なると予測されています。
主要情報
0.3%
収益成長率
-1.4%
EPS成長率
Biotechs 収益成長 | 27.3% |
収益成長率 | 5.8% |
将来の株主資本利益率 | -1.8% |
アナリストカバレッジ | Good |
最終更新日 | 04 Nov 2024 |
今後の成長に関する最新情報
Recent updates
BioNTech's Oncology Gamble: High Stakes, Big Potential
Oct 21BioNTech SE (NASDAQ:BNTX) Shares Fly 27% But Investors Aren't Buying For Growth
Sep 13BioNTech: Clinical Hold Removal Pushes ADC Development Program Forward
Aug 20BioNTech Q2 Earnings Review: No Needle-Moving Catalysts Despite Oncology Promise
Aug 06Improved Revenues Required Before BioNTech SE (NASDAQ:BNTX) Shares Find Their Feet
Jun 16BioNTech: Managements Wants 10 Oncology Drug Approvals By 2030, I'm Skeptical
Jun 13Here's Why BioNTech SE's (NASDAQ:BNTX) CEO May Not Expect A Pay Rise This Year
May 11Analyst Estimates: Here's What Brokers Think Of BioNTech SE (NASDAQ:BNTX) After Its First-Quarter Report
May 08BioNTech Earnings Preview: I Will Stay On The Sidelines
May 03BioNTech (NASDAQ:BNTX) Could Easily Take On More Debt
Apr 22We Think You Can Look Beyond BioNTech's (NASDAQ:BNTX) Lackluster Earnings
Mar 27BioNTech SE Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 24BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions
Mar 20BioNTech Buys Into Autolus' Cell Therapy Tech - Why I Expect A Full Acquisition In Time
Feb 23BioNTech SE (NASDAQ:BNTX) Shares Could Be 30% Above Their Intrinsic Value Estimate
Feb 09Growth Investors: Industry Analysts Just Upgraded Their BioNTech SE (NASDAQ:BNTX) Revenue Forecasts By 20%
Jan 18Earnings Working Against BioNTech SE's (NASDAQ:BNTX) Share Price
Jan 02BioNTech (NASDAQ:BNTX) Could Easily Take On More Debt
Dec 11Time To Worry? Analysts Are Downgrading Their BioNTech SE (NASDAQ:BNTX) Outlook
Oct 22BioNTech (NASDAQ:BNTX) Has A Rock Solid Balance Sheet
Sep 11Is BioNTech (NASDAQ:BNTX) A Risky Investment?
Jun 13A Look At The Intrinsic Value Of BioNTech SE (NASDAQ:BNTX)
May 23BioNTech SE (NASDAQ:BNTX) Analysts Just Slashed This Year's Estimates
Mar 29These 4 Measures Indicate That BioNTech (NASDAQ:BNTX) Is Using Debt Safely
Mar 05A Look At The Fair Value Of BioNTech SE (NASDAQ:BNTX)
Feb 18Bearish: Analysts Just Cut Their BioNTech SE (NASDAQ:BNTX) Revenue and EPS estimates
Feb 02With EPS Growth And More, BioNTech (NASDAQ:BNTX) Makes An Interesting Case
Jan 26業績と収益の成長予測
日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
---|---|---|---|---|---|
12/31/2026 | 2,700 | -895 | -623 | -867 | 14 |
12/31/2025 | 2,690 | -739 | -572 | -477 | 19 |
12/31/2024 | 2,558 | -791 | -22 | 233 | 9 |
9/30/2024 | 3,040 | -467 | 970 | 1,522 | N/A |
6/30/2024 | 2,691 | -504 | 2,352 | 2,972 | N/A |
3/31/2024 | 2,730 | 113 | 4,944 | 5,732 | N/A |
12/31/2023 | 3,819 | 930 | 4,666 | 5,371 | N/A |
9/30/2023 | 6,618 | 2,751 | 4,690 | 5,350 | N/A |
6/30/2023 | 9,184 | 4,375 | 8,726 | 9,317 | N/A |
3/31/2023 | 12,213 | 6,238 | 8,493 | 8,850 | N/A |
12/31/2022 | 17,311 | 9,434 | 13,214 | 13,577 | N/A |
9/30/2022 | 18,565 | 10,322 | 12,277 | 12,549 | N/A |
6/30/2022 | 21,191 | 11,748 | 9,040 | 9,271 | N/A |
3/31/2022 | 23,303 | 12,863 | 5,066 | 5,251 | N/A |
12/31/2021 | 18,977 | 10,293 | 736 | 890 | N/A |
9/30/2021 | 13,790 | 7,493 | 1,198 | 1,338 | N/A |
6/30/2021 | 7,770 | 4,072 | -474 | -355 | N/A |
3/31/2021 | 2,503 | 1,197 | -376 | -270 | N/A |
12/31/2020 | 482 | 15 | -99 | -13 | N/A |
9/30/2020 | 165 | -410 | -382 | -326 | N/A |
6/30/2020 | 126 | -230 | -239 | -183 | N/A |
3/31/2020 | 110 | -192 | -268 | -222 | N/A |
12/31/2019 | 109 | -179 | -270 | -198 | N/A |
9/30/2019 | 144 | -122 | -220 | -138 | N/A |
6/30/2019 | 136 | -116 | -142 | -75 | N/A |
3/31/2019 | 132 | -77 | -136 | -55 | N/A |
12/31/2018 | 128 | -48 | -126 | -59 | N/A |
12/31/2017 | 62 | -86 | N/A | -53 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: BNTX今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: BNTX今後 3 年間、利益が出ない状態が続くと予測されています。
高成長収益: BNTX今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: BNTXの収益 ( 5.8% ) US市場 ( 8.8% ) よりも低い成長が予測されています。
高い収益成長: BNTXの収益 ( 5.8% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: BNTX 3 年以内に赤字になると予測されています。